等级
purum
方案
≥98.0% (HPLC)
mp
~220 °C
221-223 °C (lit.)
SMILES字符串
O=S(=O)(\C=C\S(=O)(=O)c1ccccc1)c2ccccc2
InChI
1S/C14H12O4S2/c15-19(16,13-7-3-1-4-8-13)11-12-20(17,18)14-9-5-2-6-10-14/h1-12H/b12-11+
InChI key
YGBXMKGCEHIWMO-VAWYXSNFSA-N
正在寻找类似产品? 访问 产品对比指南
应用
trans-1,2-Bis(phenylsulfonyl)ethylene was used in the synthesis of (+)-7-deoxypancratistatin.
其他说明
活泼亲二烯体，Diels-Alder 反应中乙炔的便利等价物；它比顺式异构体 (15152) 的空间需求多；综述
警示用语：
Warning
危险声明
危险分类
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
13 - Non Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
A. Azzena et al.
Synthetic Communications, 18, 351-351 (1988)
L.A. Paquette et al.
Tetrahedron, 42, 1789-1789 (1986)
O. De Lucchi et al.
The Journal of Organic Chemistry, 49, 596-596 (1984)
J L Aceña et al.
Organic letters, 2(23), 3683-3686 (2000-11-14)
A new total synthesis of (+)-7-deoxypancratistatin 1 has been accomplished in 19 steps (8% overall yield) from two readly available compounds, furan and trans-1,2-bis(phenylsulfonyl)ethylene.
Sachiko Ezoe et al.
Vaccine, 38(46), 7246-7257 (2020-10-06)
BK-SE36 is blood-stage malaria vaccine candidate that is undergoing clinical trials. Here, the safety and immunogenicity of BK-SE36 with a novel adjuvant, CpG-ODN(K3) (thus, BK-SE36/CpG) was assessed in a phase 1a trial in Japan. An investigator-initiated, randomised, single-blind, placebo-controlled, dose-escalation
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持